Found: 33
Select item for more details and to access through your institution.
Expert clinical pharmacological advice may make an antimicrobial TDM program for emerging candidates more clinically useful in tailoring therapy of critically ill patients.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Linezolid Population Pharmacokinetics to Improve Dosing in Cardiosurgical Patients: Factoring a New Drug–Drug Interaction Pathway.
- Published in:
- Clinical Infectious Diseases, 2023, v. 76, n. 7, p. 1173, doi. 10.1093/cid/ciac917
- By:
- Publication type:
- Article
A 10-Year Experience of Therapeutic Drug Monitoring ( TDM) of Linezolid in a Hospital-wide Population of Patients Receiving Conventional Dosing: Is there Enough Evidence for Suggesting TDM in the Majority of Patients?
- Published in:
- Basic & Clinical Pharmacology & Toxicology, 2017, v. 121, n. 4, p. 303, doi. 10.1111/bcpt.12797
- By:
- Publication type:
- Article
Fast and Sensitive Method for Simultaneous Quantification of Meropenem and Vaborbactam in Human Plasma Microsamples by Liquid Chromatography–Tandem Mass Spectrometry for Therapeutic Drug Monitoring.
- Published in:
- Antibiotics (2079-6382), 2023, v. 12, n. 4, p. 719, doi. 10.3390/antibiotics12040719
- By:
- Publication type:
- Article
Fast and Sensitive Analysis of Cefiderocol in Human Plasma Microsamples by Liquid Chromatography-Isotope Dilution Tandem Mass Spectrometry for Therapeutic Drug Monitoring.
- Published in:
- Antibiotics (2079-6382), 2023, v. 12, n. 2, p. 213, doi. 10.3390/antibiotics12020213
- By:
- Publication type:
- Article
Population Pharmacokinetic and Pharmacodynamic Analysis of Dalbavancin for Long-Term Treatment of Subacute and/or Chronic Infectious Diseases: The Major Role of Therapeutic Drug Monitoring.
- Published in:
- Antibiotics (2079-6382), 2022, v. 11, n. 8, p. N.PAG, doi. 10.3390/antibiotics11080996
- By:
- Publication type:
- Article
Assessment of a PK/PD Target of Continuous Infusion Beta-Lactams Useful for Preventing Microbiological Failure and/or Resistance Development in Critically Ill Patients Affected by Documented Gram-Negative Infections.
- Published in:
- Antibiotics (2079-6382), 2021, v. 10, n. 11, p. 1311, doi. 10.3390/antibiotics10111311
- By:
- Publication type:
- Article
Successful Treatment of Bacteremia and Ventilator-Associated Pneumonia Caused by KPC/OXA-48-like Klebsiella pneumoniae Co-Producer with a Continuous Infusion of High-Dose Meropenem Plus Fosfomycin Guided by Real-Time Therapeutic Drug Monitoring.
- Published in:
- 2022
- By:
- Publication type:
- Case Study
Disposition of ceftobiprole during continuous venous-venous hemodiafiltration (CVVHDF) in a single critically ill patient.
- Published in:
- European Journal of Clinical Pharmacology, 2018, v. 74, n. 12, p. 1671, doi. 10.1007/s00228-018-2535-0
- By:
- Publication type:
- Article
Population pharmacokinetics of fluconazole in liver transplantation: implications for target attainment for infections with Candida albicans and non-albicans spp.
- Published in:
- European Journal of Clinical Pharmacology, 2018, v. 74, n. 11, p. 1449, doi. 10.1007/s00228-018-2526-1
- By:
- Publication type:
- Article
Higher than standard meropenem and linezolid dosages needed for appropriate treatment of an intracerebral hemorrhage patient with augmented renal clearance.
- Published in:
- 2018
- By:
- Publication type:
- Letter to the Editor
Impact of attaining aggressive vs. conservative PK/PD target on the clinical efficacy of beta-lactams for the treatment of Gram-negative infections in the critically ill patients: a systematic review and meta-analysis.
- Published in:
- Critical Care, 2024, v. 28, n. 1, p. 1, doi. 10.1186/s13054-024-04911-5
- By:
- Publication type:
- Article
Real-Life Population Pharmacokinetics of Recombinant Factor XIII and Dosing Considerations for Preventing the Risk of Bleeding in Patients with FXIII Congenital Deficiency.
- Published in:
- Clinical Pharmacokinetics, 2022, v. 61, n. 4, p. 505, doi. 10.1007/s40262-021-01079-x
- By:
- Publication type:
- Article
Population Pharmacokinetic and Pharmacodynamic Analysis for Maximizing the Effectiveness of Ceftobiprole in the Treatment of Severe Methicillin-Resistant Staphylococcal Infections.
- Published in:
- Microorganisms, 2023, v. 11, n. 12, p. 2964, doi. 10.3390/microorganisms11122964
- By:
- Publication type:
- Article
Real-Time Optimization of Pharmacodynamic Target Attainment at Infection Site during Treatment of Post-Neurosurgical Ventriculitis Caused by Carbapenem-Resistant Gram Negatives with Ceftazidime–Avibactam-Based Regimens: A Report of Two Cases.
- Published in:
- Microorganisms, 2022, v. 10, n. 1, p. 154, doi. 10.3390/microorganisms10010154
- By:
- Publication type:
- Article
Impact of Maximizing Css/MIC Ratio on Efficacy of Continuous Infusion Meropenem Against Documented Gram-Negative Infections in Critically Ill Patients and Population Pharmacokinetic/Pharmacodynamic Analysis to Support Treatment Optimization.
- Published in:
- Frontiers in Pharmacology, 2021, v. 12, p. 1, doi. 10.3389/fphar.2021.781892
- By:
- Publication type:
- Article
A Proof of Concept of the Role of TDM-Based Clinical Pharmacological Advices in Optimizing Antimicrobial Therapy on Real-Time in Different Paediatric Settings.
- Published in:
- Frontiers in Pharmacology, 2021, v. 12, p. 1, doi. 10.3389/fphar.2021.755075
- By:
- Publication type:
- Article
Successful and safe long‐term treatment of cerebral aspergillosis with high‐dose voriconazole guided by therapeutic drug monitoring.
- Published in:
- British Journal of Clinical Pharmacology, 2019, v. 85, n. 1, p. 266, doi. 10.1111/bcp.13789
- By:
- Publication type:
- Article
Co‐administration of proton pump inhibitors and/or of steroids may be a risk factor for low trough concentrations of posaconazole delayed‐released tablets in adult patients with haematological malignancies.
- Published in:
- British Journal of Clinical Pharmacology, 2018, v. 84, n. 11, p. 2544, doi. 10.1111/bcp.13707
- By:
- Publication type:
- Article
Comparative Population Pharmacokinetics of Darunavir in SARS-CoV-2 Patients vs. HIV Patients: The Role of Interleukin-6.
- Published in:
- Clinical Pharmacokinetics, 2020, v. 59, n. 10, p. 1251, doi. 10.1007/s40262-020-00933-8
- By:
- Publication type:
- Article
Valganciclovir Pharmacokinetics in Patients Receiving Oral Prophylaxis Following Kidney Transplantation and Model-Based Predictions of Optimal Dosing Regimens.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Azacitidine for Acute Myeloid Leukemia: Why One Dose Does Not Fit All.
- Published in:
- Clinical Pharmacology & Therapeutics, 2024, v. 115, n. 3, p. 403, doi. 10.1002/cpt.3154
- By:
- Publication type:
- Article
Real-time TDM-based optimization of continuous-infusion meropenem for improving treatment outcome of febrile neutropenia in oncohaematological patients: results from a prospective, monocentric, interventional study.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Proactive therapeutic drug monitoring (TDM) may be helpful in managing long-term treatment with linezolid safely: findings from a monocentric, prospective, open-label, interventional study.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Population pharmacokinetics of continuous-infusion ceftazidime in febrile neutropenic children undergoing HSCT: implications for target attainment for empirical treatment against Pseudomonas aeruginosa.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Population pharmacokinetics and dosing considerations for the use of daptomycin in adult patients with haematological malignancies.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2017, v. 72, n. 8, p. 2342, doi. 10.1093/jac/dkx140
- By:
- Publication type:
- Article
Population pharmacokinetics and dosing considerations for the use of daptomycin in adult patients with haematological malignancies.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Effect of incremental tazobactam concentrations on the bactericidal activity of piperacillin against ESBL-producing enterobacterales clinical isolates causing bacteraemia.
- Published in:
- European Journal of Clinical Microbiology & Infectious Diseases, 2024, v. 43, n. 9, p. 1861, doi. 10.1007/s10096-024-04879-8
- By:
- Publication type:
- Article
A Sensitive Liquid Chromatography–Tandem Mass Spectrometry Method for Measuring Fosfomycin Concentrations in Human Prostatic Tissue.
- Published in:
- Pharmaceutics, 2024, v. 16, n. 5, p. 681, doi. 10.3390/pharmaceutics16050681
- By:
- Publication type:
- Article
Does Cytokine-Release Syndrome Induced by CAR T-Cell Treatment Have an Impact on the Pharmacokinetics of Meropenem and Piperacillin/Tazobactam in Patients with Hematological Malignancies? Findings from an Observational Case-Control Study.
- Published in:
- Pharmaceutics, 2023, v. 15, n. 3, p. 1022, doi. 10.3390/pharmaceutics15031022
- By:
- Publication type:
- Article
Measuring Creatinine Clearance Is the Most Accurate Way for Calculating the Proper Continuous Infusion Meropenem Dose for Empirical Treatment of Severe Gram-Negative Infections among Critically Ill Patients.
- Published in:
- Pharmaceutics, 2023, v. 15, n. 2, p. 551, doi. 10.3390/pharmaceutics15020551
- By:
- Publication type:
- Article
Fast and Simple Liquid Chromatography-Isotope Dilution Tandem Mass Spectrometry Method for Therapeutic Drug Monitoring of Dalbavancin in Long-Term Treatment of Subacute and/or Chronic Infections.
- Published in:
- Pharmaceutics, 2023, v. 15, n. 2, p. 480, doi. 10.3390/pharmaceutics15020480
- By:
- Publication type:
- Article
Population Pharmacokinetics of Continuous-Infusion Meropenem in Febrile Neutropenic Patients with Hematologic Malignancies: Dosing Strategies for Optimizing Empirical Treatment against Enterobacterales and P. aeruginosa.
- Published in:
- Pharmaceutics, 2020, v. 12, n. 9, p. 785, doi. 10.3390/pharmaceutics12090785
- By:
- Publication type:
- Article